Biofilm buster treats drug-resistant infections

January 10, 2018

Scientists have created a potent antibacterial agent that killed drug-resistant microbes and even eradicated stubborn pathogens growing in biofilms, which can be 10 to 1,000 times more tolerant to antibiotics than free-living bacteria. They say the compound, a short protein fragment called SAAP-148, could be a promising drug candidate in the ongoing battle against antibiotic-resistant bacteria. An increasing number of dangerous bacteria are becoming impervious to multiple antibiotics, raising the alarming prospect of untreatable infections killing large numbers of patients. Seeking alternatives to conventional antibiotics, Anna de Breij and colleagues made modified versions of a human antimicrobial peptide called LL-37, which serves as one of the primary innate immune defenses for fighting bacteria by poking holes in their outer membranes. After screening hundreds of peptides for antibacterial activity, de Breij et al. narrowed in on SAAP-148. They showed that SAAP-148 killed several multidrug resistant bacteria belonging to the ESKAPE panel (a pernicious group of pathogens noted by the Infectious Diseases Society of America for their potential to escape antibiotics and cause human harm) without causing resistance. SAAP-148 eliminated bacteria growing in biofilms in culture - even killing the highly resistant populations of so-called "persister cells," which exist in a dormant, drug-tolerant state that can drive the reemergence of infections after antibiotic treatment. What's more, an ointment containing the peptide effectively treated MRSA and Acinetobacter baumannii infected wounds in mice and on samples of ex vivo human skin. A clinical trial to further investigate the ointment is scheduled for 2018, the authors say.

American Association for the Advancement of Science

Related Antibiotics Articles from Brightsurf:

Insights in the search for new antibiotics
A collaborative research team from the University of Oklahoma, the Memorial Sloan Kettering Cancer Center and Merck & Co. published an opinion article in the journal, Nature Chemical Biology, that addresses the gap in the discovery of new antibiotics.

New tricks for old antibiotics
The study published in the journal Immunity reveals that tetracyclines (broad spectre antibiotics), by partially inhibiting cell mitochondria activity, induce a compensatory response on the organism that decreases tissue damage caused during infection.

Benefits, risks seen with antibiotics-first for appendicitis
Antibiotics are a good choice for some patients with appendicitis but not all, according to study results published today in the New England Journal of Medicine.

How antibiotics interact
Understanding bottleneck effects in the translation of bacterial proteins can lead to a more effective combination of antibiotics / study in 'Nature Communications'

Are antivitamins the new antibiotics?
Antibiotics are among the most important discoveries of modern medicine and have saved millions of lives since the discovery of penicillin almost 100 years ago.

Hygiene reduces the need for antibiotics by up to 30%
A new paper published in the American Journal of Infection Control (AJIC), finds improved everyday hygiene practices, such as hand-washing, reduces the risk of common infections by up to 50%, reducing the need for antibiotics, by up to 30%.

Antibiotics: City dwellers and children take the most
City dwellers take more antibiotics than people in rural areas; children and the elderly use them more often than middle-aged people; the use of antibiotics decreases as education increases, but only in rich countries: These are three of the more striking trends identified by researchers of the NRW Forschungskolleg ''One Health and Urban Transformation'' at the University of Bonn.

Metals could be the link to new antibiotics
Compounds containing metals could hold the key to the next generation of antibiotics to combat the growing threat of global antibiotic resistance.

Antibiotics from the sea
The team led by Prof. Christian Jogler of Friedrich Schiller University, Jena, has succeeded in cultivating several dozen marine bacteria in the laboratory -- bacteria that had previously been paid little attention.

Antibiotics not necessary for most toothaches, according to new ADA guideline
The American Dental Association (ADA) announced today a new guideline indicating that in most cases, antibiotics are not recommended for toothaches.

Read More: Antibiotics News and Antibiotics Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to